DLBS1033 for the Treatment of Acute Ischemic Stroke


Phase 3 Results N/A

Summary of Purpose

This is a prospective, randomized, double-blind, and controlled clinical study to investigate the effects of DLBS1033 in conjunction with standard therapy compared to standard therapy alone in acute ischemic stroke patients. Trial Stopped: Major technical hindrance in recruitment.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 2 May 2017.

1 Oct 2014 3 Feb 2015 1 Feb 2017 1 Apr 2017 1 May 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment


See All